Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Aug 6, 2024; 12(22): 4999-5007
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4999
Table 1 Comparison table of basic data of research subjects, n (%)

Study group (n = 40)
Control group (n = 40)
χ2/t
P value
Age (year)56.182 ± 5.17456.744 ± 4.9560.4960.621
Sex (number of people)        0.0510.822
        Male23 (57.5)22 (55.0)
        Female17 (42.5)18 (45.0)
Pathological examination (number of people)0.2120.976
        Craniocerebral trauma13 (32.5)12 (30.0)
        Cerebrovascular disease10 (25.0)11 (27.5)
Brain tumor11 (27.5)10 (25.0)
Others6 (15.0)7 (17.5)
Pathological grading (number of people)0.3470.841
        Level I6 (15.0)8 (20.0)
        Level II16 (40)15 (37.5)
        Level III18 (45.0)17 (42.5)
Surgical method (number of people)0.1200.942
        Emergency neurosurgical surgery13 (32.5)12 (30.0)
        Vascular neurosurgery10 (25.0)11 (27.5)
        Tumor neurosurgery surgery11 (27.5)10 (25.0)
Average duration of illness (year)3.212 ± 0.0283.214 ± 0.0160.3920.696
Hospitalization days (day)120.212 ± 0.321120.221 ± 0.2410.1420.888
Follow up time (month)8.654 ± 0.3528.587 ± 0.3140.8980.372
Adjuvant therapy (number of people)20 (50.0)18 (45.0)0.2010.654